Skip to main content

Table 1 Baseline clinicopathological characteristics of the 130 nasopharyngeal cancer patients

From: Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy

Variable Number of patients %
Gender   
Male 88 67.7
Female 42 32.3
Age   
< 45 years 61 53.1
≥ 45 years 69 46.9
Karnofsky performance score   
< 90 11 8.5
≥ 90 119 91.5
T category*   
T1/T2/T3/T4 13/19/70/28 10/14.6/53.8/21.5
N category*   
N0/N1/N2/N3 31/40/53/6 23.8/30.8/40.8/4.6
Stage*   
I/II/III/IVa 7/17/73/33 5.4/13.1/56.2/56.2
Chemotherapy   
Radiotherapy alone 37 71.5
Chemoradiotherapy 93 28.5
  1. * According to the 7th edition of the American Joint Committee on Cancer/International Union Against Cancer staging system.